Skip to main content
Clinical Trials/NCT05569525
NCT05569525Active, not recruitingNot Applicable

Effects of Non-surgical Periodontal Therapy on the Glycemic Variability of Periodontal Patients Affected by Type I Diabetes. a Randomized Clinical Trial.

University of Florence2 sites in 1 country100 target enrollmentStarted: November 6, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
100
Locations
2
Primary Endpoint
Glycated hemoglobin (HbA1c)

Study Overview

Brief Summary

Current evidence suggests a bidirectional association between periodontitis and diabetes. Periodontal therapy improves short term HbA1c levels and is safe to perform. Most studies are focused on type 2 Diabetes. Literature about the correlation between periodontitis and type 1 diabetes is scarce, since no randomized clinical trials have been performed.

The objective of the present clinical investigation is to evaluate the effects of nonsurgical treatment of periodontal disease on glycemic variability in patients with type 1 diabetes (T1DM). The hypothesis is that nonsurgical periodontal therapy affects glycemic variability in terms of time spent in hyperglycemia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of Type 1 diabetes
  • Patients under treatment in the department of Diabetology of AOU Careggi having a microinfusor for continuous subcutaneous insulin infusion (CSII) and a Flash Glucose Monitoring (FGM) device
  • Diagnosis of periodontitis (all stages and grades)

Exclusion Criteria

  • Contraindications for non-surgical periodontal therapy
  • Pregnancy
  • History of other systemic disease (cancer, HIV, bone metabolic dysease, Head and Neck Radiotherapy, Immunosuppressive/modulating therapy)

Outcomes

Primary Outcomes

Glycated hemoglobin (HbA1c)

Time Frame: 6 months after the non-surgical periodontal treatment

Glycated hemoglobin (HbA1c) to evaluate glycemic variability measured as a percentage (%).

Secondary Outcomes

  • Standard Deviation (SD) of glycaemia(6 months after the non-surgical periodontal treatment)
  • Glucose coefficient of variability (CV)(6 months after the non-surgical periodontal treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Francesco Cairo

Prof.

University of Florence

Study Sites (2)

Loading locations...

Similar Trials